Why is Nectar Lifesci. falling/rising?

As of 04-Sep, Nectar Lifescience Ltd's stock price is currently at 14.75, reflecting an increase of 0.14 or 0.96%. The stock has shown a positive trend recently, gaining 3.22% over the last three days and outperforming its sector by 1.11%. However, despite this short-term gain, the stock has a troubling long-term performance, with a year-to-date decline of 62.18% and a one-year return of -63.53%. The company is facing significant challenges, including operating losses, a high debt-to-EBITDA ratio of 7.73 times, and negative earnings before interest, taxes, depreciation, and amortization (EBITDA). Additionally, 99.6% of promoter shares are pledged, which adds downward pressure on the stock price in a declining market.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has only gained 0.07% over the past week while the Sensex increased by 0.80%. This underperformance is indicative of the company's struggles, especially given its negative financial results, such as a 32.9% decline in net sales and a 122.5% drop in profit after tax compared to previous quarters. The stock's liquidity remains adequate for trading, but the falling investor participation, as evidenced by a 21.74% decrease in delivery volume, suggests waning interest among investors. Overall, while there is a slight uptick in the stock price recently, the underlying financial issues and market conditions continue to pose significant risks.